Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
According to numerous animal studies, adverse environmental stimuli, including physical, chemical, and biological factors, can cause low‐grade chronic inflammation and subsequent tumor development. Human epidemiological evidence has confirmed the close relationship between chronic inflammation and tumorigenesis. However, the mechanisms driving the development of persistent inflammation toward tumorigenesis remain unclear. In this study, we assess the potential role of reactive oxygen species (ROS) and associated mechanisms in modulating inflammation‐induced tumorigenesis. Recent reports have emphasized the cross‐talk between oxidative stress and inflammation in many pathological processes. Exposure to carcinogenic environmental hazards may lead to oxidative damage, which further stimulates the infiltration of various types of inflammatory cells. In turn, increased cytokine and chemokine release from inflammatory cells promotes ROS production in chronic lesions, even in the absence of hazardous stimuli. Moreover, ROS not only cause DNA damage but also participate in cell proliferation, differentiation, and apoptosis by modulating several transcription factors and signaling pathways. We summarize how changes in the redox state can trigger the development of chronic inflammatory lesions into tumors. Generally, cancer cells require an appropriate inflammatory microenvironment to support their growth, spread, and metastasis, and ROS may provide the necessary catalyst for inflammation‐driven cancer. In conclusion, ROS bridge the gap between chronic inflammation and tumor development; therefore, targeting ROS and inflammation represents a new avenue for the prevention and treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: New Dimensions
Hanahan, D. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1059 · Cited by 9,887
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994 · cited 1×
“In fl ammatory cells in the TME promote cancer cell metastasis through the release of several adhesion molecules and chemokines, such as intercellular cell adhesion molecule-1 (ICAM-1) and matrix metalloproteinases (MMPs) [143, 199].”
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“These antioxidant enzymes and GSH are modulated by several redox signaling transcription factors, including Nrf2, PGC-1a, and P53 [46, 50].”
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602 · cited 1×
“found that mitophagy inhibition boosts the NLRP3 inflammasome by inducing mitochondrial damage and ROS generation [97].”
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335 · cited 1×
“However, emerging evidence indicates that ROS exert many ben-e fi cial biological e ff ects through regulating a series of transcriptional and phosphorylation processes [45, 57, 58].”
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737 · cited 1×
“However, more recent epidemiological studies have found that the supplementation of antioxidants has a minimal preventive and therapeutic e ff ect on cancers and may even lead to adverse e ff ects [262 – 264].”
Inflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 4×
“It is now widely accepted that chronic inflammation is implicated in various steps of carcinogenesis, such as cell malignant transformation, proliferation, migration, and resistance to chemotherapy and radiotherapy [9, 69, 142, 143].”
InfluentialMizrahi, J. D., Surana, R., Valle, J. W., & Shroff, R. T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30974-0 · Cited by 2,559
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
Mills, E. L., Kelly, B., Logan, A., Costa, A. S. H., Varma, M., Bryant, C. E., Tourlomousis, P., Däbritz, J. H. M., Gottlieb, E., Latorre, I., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.064 · Cited by 2,291 · cited 1×
“Many TCA cycle metabolic enzymes are implicated in regulating ROS production, such as succinate dehydrogenase, malic enzyme, and NAPDH oxidase [48, 49].”
Lenis, A. T., Lec, P. M., Chamie, K., & MSHS, M. (2020) · JAMA · doi:10.1001/jama.2020.17598 · Cited by 2,051
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474 · cited 1×
“TAMs, the dominant immune cells in the TME, contribute to cancer chemotherapy resistance by releasing survival factors or activating antiapoptotic programs in malignant cells [234, 235].”
STING: infection, inflammation and cancer.
Barber, G. N. (2015) · Nature Reviews Immunology · doi:10.1038/nri3921 · Cited by 1,313 · cited 1×
“Emerging studies have suggested that continuous exposure to toxic and infectious substances exacerbates inflammatory responses, which may underlie neoplastic progression [10].”
Targeting Free Radicals in Oxidative Stress-Related Human Diseases
Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C. J., & Valko, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.005 · Cited by 1,107 · cited 1×
“Excess ROS result in oxidative damage to the major constituents of living cells, including proteins, lipids, and DNA, ultimately contributing to a wide spectrum of pathophysiologies, such as sepsis, aging, obesity, cancer, diabetes, depression, and neurodegeneration [55, 56].”
CD8+ T cell differentiation and dysfunction in cancer
Philip, M., & Schietinger, A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00574-3 · Cited by 1,052 · cited 1×
“Cytotoxic CD8 + T cells can directly kill tumor cells, reportedly the most powerful weapon for cancer immunotherapy [125, 126].”
Necroptosis in development, inflammation and disease
Weinlich, R., Oberst, A., Beere, H. M., & Green, D. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.149 · Cited by 1,016
TNF and ROS crosstalk in inflammation
Blaser, H., Dostert, C., Mak, T. W., & Brenner, D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.12.002 · Cited by 1,008 · cited 1×
“Moreover, in fl ammatory cells and associated cytokines contribute to disrupting redox balance in tumor cells [116].”
Role of Glutathione in Cancer: From Mechanisms to Therapies
Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M. (2020) · Biomolecules · doi:10.3390/biom10101429 · Cited by 880 · cited 3×
“Inhibition of GPX1 activity and GSH synthesis are also associated with reduced proliferative capacity in various tumor cells [120, 121].”
Macrophage-Based Approaches for Cancer Immunotherapy
Anderson, N. R., Minutolo, N. G., Gill, S., & Klichinsky, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2990 · Cited by 698
Roh, J.-L., Kim, E. H., Jang, H., & Shin, D. (2017) · Redox Biology · doi:10.1016/j.redox.2016.12.010 · Cited by 662
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Fujiwara, N., Friedman, S. L., Goossens, N., & Hoshida, Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.016 · Cited by 659
Halliwell, B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02075-4 · Cited by 655 · cited 1×
“In 2000, Halliwell first proposed the concept of the antioxidant paradox in The Lancet, which refutes the value of antioxidants in tumor treatment [265].”
Antioxidants can increase melanoma metastasis in mice
Le Gal, K., Ibrahim, M. X., Wiel, C., Sayin, V. I., Akula, M. K., Karlsson, C., Dalin, M. G., Akyürek, L. M., Lindahl, P., Nilsson, J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3740 · Cited by 632 · cited 2×
“Third, many studies have documented the role of antioxidant agents and Nrf2 activation in accelerating tumor metastasis; however, the related mechanisms remain unclear [119, 279, 280].”
BACH1 Stabilization by Antioxidants Stimulates Lung Cancer Metastasis
Wiel, C., Le Gal, K., Ibrahim, M. X., Jahangir, C. A., Kashif, M., Yao, H., Ziegler, D. V., Xu, X., Ghosh, T., Mondal, T., et al. (2019) · Cell · doi:10.1016/j.cell.2019.06.005 · Cited by 579
Clearance of apoptotic neutrophils and resolution of inflammation
Greenlee‐Wacker, M. C. (2016) · Immunological Reviews · doi:10.1111/imr.12453 · Cited by 478
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
Oh, D. Y., & Fong, L. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.015 · Cited by 467 · cited 1×
“CD4 + helper T cells (Th), such as Th1, Th2, and Th17, also a ff ect CD8 + T cell proliferation and cytotoxicity by secreting a series of in fl ammatory cytokines [127].”
The multifaceted role of reactive oxygen species in tumorigenesis
Kirtonia, A., Sethi, G., & Garg, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03536-5 · Cited by 452 · cited 2×
“ROS reportedly trigger EMT by activating various pathways, including E-cadherin, N-cadherin, vimentin, and Snail [209].”
Fortmann, S. P., Burda, B. U., Senger, C. A., Lin, J. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00729 · Cited by 442 · cited 2×
“Selenium Eggs, kidneys, oysters, konjac, alfalfa [283, 285]”
Targeting cancer vulnerabilities with high-dose vitamin C
Ngo, B., Van Riper, J. M., Cantley, L. C., & Yun, J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0135-7 · Cited by 423 · cited 2×
“More-over, vitamin C intake below the recommended allowance leads to increased DNA oxidative damage, whereas the consumption of high-dose vitamin C can kill cancer cells [272, 273].”
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Halbrook, C. J., Pontious, C., Kovalenko, I., Lapienyte, L., Dreyer, S., Lee, H.-J., Thurston, G., Zhang, Y., Lazarus, J., Sajjakulnukit, P., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.02.001 · Cited by 419 · cited 1×
“Pyrimidine, cholesterol, IL-6, and exosomal miRNA released by TAMs are also associated with enhanced therapy resistance in various cancer cells [238 – 240].”
Redox control of inflammation in macrophages
Brüne, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., & Weigert, A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4785 · Cited by 377 · cited 2×
“Proinflammatory cytokines also boost ROS accumulation in both phagocytic and nonphagocytic cells, leading to oxidative stress in various acute and chronic diseases [94, 95].”
Redox control of senescence and age-related disease.
Chandrasekaran, A., Idelchik, M. D. P. S., & Melendez, J. A. (2017) · Redox Biology · doi:10.1016/j.redox.2016.11.005 · Cited by 360 · cited 1×
“Excess ROS result in oxidative damage to the major constituents of living cells, including proteins, lipids, and DNA, ultimately contributing to a wide spectrum of pathophysiologies, such as sepsis, aging, obesity, cancer, diabetes, depression, and neurodegeneration [55, 56].”
Frodermann, V., Rohde, D., Courties, G., Severe, N., Schloss, M. J., Amatullah, H., McAlpine, C. S., Cremer, S., Hoyer, F. F., Ji, F., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0633-x · Cited by 292
Dietary patterns and cancer risk
Steck, S. E., & Murphy, E. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0227-4 · Cited by 292 · cited 1×
“Typically, tumorigenesis is attributed to unhealthy lifestyles and environmental pollution [2, 3].”
High-dose vitamin C enhances cancer immunotherapy
Magrì, A., Germano, G., Lorenzato, A., Lamba, S., Chilà, R., Montone, M., Amodio, V., Ceruti, T., Sassi, F., Arena, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8707 · Cited by 285 · cited 1×
“Several mechanisms have been proposed to illustrate the anticancer e ff ects of high-dose vitamin C, such as induction of ROS accumulation, epigenetic reprogramming, enhanced immunotherapy e ffi cacy, and inhibition of HIF1 α -induced hypoxia adaptation [272, 274, 275].”
Saenen, N. D., Martens, D. S., Neven, K. Y., Alfano, R., Bové, H., Janssen, B. G., Roels, H. A., Plusquin, M., Vrijens, K., & Nawrot, T. S. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0688-z · Cited by 267 · cited 1×
“For example, heavy metal and inhalable particles can result in severe mitochondrial damage and substantial ROS production [52].”
Is resolution the end of inflammation?
Feehan, K. T., & Gilroy, D. W. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.01.006 · Cited by 229 · cited 2×
“If the irritations persist, aggregation of inflammatory cells and cytokines can transform acute inflammation into the chronic stage, potentially inducing local and systemic deleterious effects [62].”
NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma
Wilson, C. L., Jurk, D., Fullard, N., Banks, P., Page, A., Luli, S., Elsharkawy, A. M., Gieling, R. G., Chakraborty, J. B., Fox, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7818 · Cited by 171 · cited 5×
“In DEN-treated mice, the accumulation of hepatic neutrophils stimulates hepatocellular ROS generation and telomere DNA damage, which is ameliorated by antioxidant agents [117].”
InfluentialRoles of UVA radiation and DNA damage responses in melanoma pathogenesis
Khan, A. Q., Travers, J. B., & Kemp, M. G. (2018) · Environmental and Molecular Mutagenesis · doi:10.1002/em.22176 · Cited by 152 · cited 1×
“In addition, phorbol 12-myristate 13-acetate (PMA) and UV exposure led to 8-OHdG accumulation in the skin of animals [164, 165].”
Precision Redox: The Key for Antioxidant Pharmacology
Meng, J., Lv, Z., Zhang, Y., Wang, Y., Qiao, X., Sun, C., Chen, Y., Guo, M., Han, W., Ye, A., et al. (2021) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8212 · Cited by 122 · cited 2×
“To achieve precise and e ff ective regulation of the intracellular redox state, antioxidant pharmacology should follow the “ 5R ” principles, that is, “ right species, right place, right time, right level, and right target ” [61].”
Self-citationChen, L., Shi, Y., Zhu, X., Guo, W., Zhang, M., Che, Y., Tang, L., Yang, X., You, Q., & Liu, Z. (2019) · Oncology Reports · doi:10.3892/or.2019.7206 · Cited by 92 · cited 1×
“Moreover, IL-10 secreted by TAM regulates proliferation and invasion in gastric cancer cell STAT3 signaling [193], and IL-6 stimulation promotes the increased proliferation of cancer cells [194].”
Shearn, C. T., Reigan, P., & Petersen, D. R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.04.021 · Cited by 42 · cited 2×
“Shearn et al. proved that 4-hydroxynonenal reduces cell survival in hepatocellular carcinoma by inhibiting H 2 O 2 -dependent Akt activation [181].”
Metadata
- Authors
- Yu, W., Tu, Y., Long, Z., Liu, J., Kong, D., Peng, J., Wu, H., Zheng, G., Zhao, J., Chen, Y., Liu, R., Li, W., & Hai, C.
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2022-01
- Volume
- 2022
- Issue
- 1
- Pages
- 2606928-2606928
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- OpenAlex
- W4283698994
- Cited by
- 161
- References
- 44
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.